FDA Approves Marketing of Roche Diagnostics MRSA Diagnostic Test
December 05 2019 - 1:10PM
Dow Jones News
By Stephen Nakrosis
The U.S. Food and Drug Administration said Thursday it
authorized the marketing of Roche Molecular Systems Inc.'s
diagnostic test to detect Methicillin-resistant Staphylococcus
aureus, or MRSA, bacteria.
The FDA said the test "may allow health care professionals to
evaluate patients for colonization with MRSA bacteria more quickly
than traditional culture-based techniques."
The new test can detect the presence of MRSA from a nasal swab
in as little as five hours, the FDA said, compared to the 24 to 48
hours a conventional diagnosis may take.
Roche Molecular Systems is part of Roche Holding AG.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
December 05, 2019 12:55 ET (17:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
